Treatment of filarial diseases
US10238677B2 · kind B2 · utility
0Cited by
2References
28Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 8, 2016 |
| Grant date | Mar 26, 2019 |
| Priority date | — |
| Expiry date | Jan 8, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention pertains to prevention of and/or treatment for filariasis. In particular, the present invention pertains to the use of tylosin A and its analogs and derivatives to prevent or treat filarial worm infection and/or diseases associated with filarial worm infection. The present invention also pertains to pharmaceutical compositions comprising tylosin A or an analog or derivative thereof for use in preventing or treating filarial worm infection and/or diseases associated with filarial worm infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.